Literature DB >> 27241210

Impairment of chemical clearance and mucosal integrity distinguishes hypersensitive esophagus from functional heartburn.

Marzio Frazzoni1, Nicola de Bortoli2, Leonardo Frazzoni3, Manuele Furnari4, Irene Martinucci2, Salvatore Tolone5, Andrea Farioli3, Santino Marchi2, Lorenzo Fuccio3, Vincenzo Savarino4, Edoardo Savarino6.   

Abstract

BACKGROUND: Hypersensitive esophagus (HE) is defined by endoscopy-negative heartburn with a normal acid exposure time but positive symptom association probability (SAP) and/or symptom index (SI) on impedance-pH monitoring, and proton pump inhibitor (PPI) responsiveness. Functional heartburn (FH) is distinguished by negative SAP/SI and PPI refractoriness. The clinical value of SAP and SI has been questioned. We aimed to investigate whether impairment of chemical clearance and of mucosal integrity, expressed by the postreflux swallow-induced peristaltic wave (PSPW) index and the mean nocturnal baseline impedance (MNBI), characterize HE independently of SAP and SI.
METHODS: Impedance-pH tracings from PPI-responsive endoscopy-negative patients, 125 with nonerosive reflux disease and 108 with HE, distinguished by an abnormal and a normal acid exposure time, and from 70 patients with FH were retrospectively selected and blindly reviewed.
RESULTS: The mean PSPW index and MNBI were significantly lower in nonerosive reflux disease (30 %, 1378 Ω) than in HE (51 %; 2274 Ω) and in both of them as compared with FH (76 %; 3445 Ω) (P = 0.0001). Both the PSPW index (adjusted odds ratio 0.863, P = 0.001) and the MNBI (adjusted odds ratio 0.998, P = 0.001) were independent predictors of HE; with their combined assessment, the area under the curve on receiver operating characteristic analysis was 0.957. SAP and/or SI was positive in 67 of the 108 HE patients (62 %), whereas the PSPW index and/or MNBI was abnormal in 99 of the 108 HE patients (92 %; P < 0.0001).
CONCLUSIONS: HE is characterized by impairment of chemical clearance and mucosal integrity, which explains the increased reflux perception. When SAP and SI afford uncertain results, the PSPW index and MNBI should be analyzed.

Entities:  

Keywords:  Functional heartburn; GERD; Hypersensitive esophagus; pH Impedance monitoring

Mesh:

Substances:

Year:  2016        PMID: 27241210     DOI: 10.1007/s00535-016-1226-9

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  41 in total

1.  In vivo evaluation of acid-induced changes in oesophageal mucosa integrity and sensitivity in non-erosive reflux disease.

Authors:  Philip Woodland; Mohannad Al-Zinaty; Etsuro Yazaki; Daniel Sifrim
Journal:  Gut       Date:  2012-06-21       Impact factor: 23.059

2.  Reflux parameters as modified by EsophyX or laparoscopic fundoplication in refractory GERD.

Authors:  M Frazzoni; R Conigliaro; R Manta; G Melotti
Journal:  Aliment Pharmacol Ther       Date:  2011-05-03       Impact factor: 8.171

3.  Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy.

Authors:  Edoardo Savarino; Radu Tutuian; Patrizia Zentilin; Pietro Dulbecco; Daniel Pohl; Elisa Marabotto; Andrea Parodi; Giorgio Sammito; Lorenzo Gemignani; Giorgia Bodini; Vincenzo Savarino
Journal:  Am J Gastroenterol       Date:  2009-12-08       Impact factor: 10.864

4.  Reflux parameters as modified by laparoscopic fundoplication in 40 patients with heartburn/regurgitation persisting despite PPI therapy: a study using impedance-pH monitoring.

Authors:  Marzio Frazzoni; Rita Conigliaro; Gianluigi Melotti
Journal:  Dig Dis Sci       Date:  2010-08-25       Impact factor: 3.199

Review 5.  Functional esophageal disorders.

Authors:  Jean Paul Galmiche; Ray E Clouse; András Bálint; Ian J Cook; Peter J Kahrilas; William G Paterson; Andre J P M Smout
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

6.  Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy.

Authors:  Frank Zerbib; Sabine Roman; Alain Ropert; Stanislas Bruley des Varannes; Philippe Pouderoux; Ulriikka Chaput; François Mion; Eric Vérin; Jean-Paul Galmiche; Daniel Sifrim
Journal:  Am J Gastroenterol       Date:  2006-07-18       Impact factor: 10.864

Review 7.  NERD: an umbrella term including heterogeneous subpopulations.

Authors:  Edoardo Savarino; Patrizia Zentilin; Vincenzo Savarino
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-26       Impact factor: 46.802

8.  Neoplastic progression in short-segment Barrett's oesophagus is associated with impairment of chemical clearance, but not inadequate acid suppression by proton pump inhibitor therapy.

Authors:  M Frazzoni; H Bertani; R Conigliaro; L Frazzoni; L Losi; G Melotti
Journal:  Aliment Pharmacol Ther       Date:  2014-08-04       Impact factor: 8.171

9.  24-hour pH-impedance monitoring on therapy to select patients with refractory reflux symptoms for antireflux surgery. A single center retrospective study.

Authors:  M Desjardin; G Luc; D Collet; F Zerbib
Journal:  Neurogastroenterol Motil       Date:  2015-11-03       Impact factor: 3.598

10.  Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease.

Authors:  E Savarino; D Pohl; P Zentilin; P Dulbecco; G Sammito; L Sconfienza; S Vigneri; G Camerini; R Tutuian; V Savarino
Journal:  Gut       Date:  2009-05-20       Impact factor: 23.059

View more
  24 in total

Review 1.  Advances in the Diagnosis and Treatment of GERD: New Tricks for an Old Disease.

Authors:  Rishi D Naik; Lauren Evers; Michael F Vaezi
Journal:  Curr Treat Options Gastroenterol       Date:  2019-03

Review 2.  Expert consensus document: Advances in the physiological assessment and diagnosis of GERD.

Authors:  Edoardo Savarino; Albert J Bredenoord; Mark Fox; John E Pandolfino; Sabine Roman; C Prakash Gyawali
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-09-27       Impact factor: 46.802

3.  Esophageal High-Resolution Manometry Can Unravel the Mechanisms by Which Different Bariatric Techniques Produce Different Reflux Exposures.

Authors:  Salvatore Tolone; Edoardo Savarino; Nicola de Bortoli; Marzio Frazzoni; Leonardo Frazzoni; Vincenzo Savarino; Ludovico Docimo
Journal:  J Gastrointest Surg       Date:  2019-10-16       Impact factor: 3.452

4.  Elimination of Dietary Triggers Is Successful in Treating Symptoms of Gastroesophageal Reflux Disease.

Authors:  Cesare Tosetti; Edoardo Savarino; Edoardo Benedetto; Rudi De Bastiani
Journal:  Dig Dis Sci       Date:  2020-06-24       Impact factor: 3.199

5.  Distal mean nocturnal baseline impedance on pH-impedance monitoring predicts reflux burden and symptomatic outcome in gastro-oesophageal reflux disease.

Authors:  A Patel; D Wang; N Sainani; G S Sayuk; C P Gyawali
Journal:  Aliment Pharmacol Ther       Date:  2016-08-24       Impact factor: 8.171

Review 6.  Impedance-pH Monitoring for Diagnosis of Reflux Disease: New Perspectives.

Authors:  Marzio Frazzoni; Nicola de Bortoli; Leonardo Frazzoni; Salvatore Tolone; Vincenzo Savarino; Edoardo Savarino
Journal:  Dig Dis Sci       Date:  2017-05-26       Impact factor: 3.199

7.  ACG Clinical Guidelines: Clinical Use of Esophageal Physiologic Testing.

Authors:  C Prakash Gyawali; Dustin A Carlson; Joan W Chen; Amit Patel; Robert J Wong; Rena H Yadlapati
Journal:  Am J Gastroenterol       Date:  2020-09       Impact factor: 12.045

8.  The Spectrum of Reflux Phenotypes.

Authors:  Lisa B Mahoney; Rachel Rosen
Journal:  Gastroenterol Hepatol (N Y)       Date:  2019-12

9.  Value of adjunctive evidence from MII-pH monitoring and high-resolution manometry in inconclusive GERD patients with AET 4-6.

Authors:  Ya Jiang; Liuqin Jiang; Bixing Ye; Lin Lin
Journal:  Therap Adv Gastroenterol       Date:  2021-05-30       Impact factor: 4.409

Review 10.  Drugs for improving esophageal mucosa defense: where are we now and where are we going?

Authors:  Edoardo Savarino; Patrizia Zentilin; Elisa Marabotto; Gaia Pellegatta; Claudia Coppo; Matteo Brunacci; Pietro Dulbecco; Vincenzo Savarino
Journal:  Ann Gastroenterol       Date:  2017-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.